Sana D. Karam

6.0k total citations
162 papers, 3.3k citations indexed

About

Sana D. Karam is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Sana D. Karam has authored 162 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Oncology, 55 papers in Pulmonary and Respiratory Medicine and 47 papers in Otorhinolaryngology. Recurrent topics in Sana D. Karam's work include Head and Neck Cancer Studies (45 papers), Cancer Immunotherapy and Biomarkers (29 papers) and Axon Guidance and Neuronal Signaling (16 papers). Sana D. Karam is often cited by papers focused on Head and Neck Cancer Studies (45 papers), Cancer Immunotherapy and Biomarkers (29 papers) and Axon Guidance and Neuronal Signaling (16 papers). Sana D. Karam collaborates with scholars based in United States, Japan and Canada. Sana D. Karam's co-authors include David Raben, Ayman Oweida, Laurel B. Darragh, Jessica D. McDermott, Shilpa Bhatia, Bernard L. Jones, Arya Amini, Daniel W. Bowles, Arya Amini and Andy V. Phan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Sana D. Karam

150 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sana D. Karam United States 32 1.7k 888 826 703 668 162 3.3k
Seungwon Kim United States 36 1.8k 1.1× 831 0.9× 1.5k 1.9× 1.6k 2.3× 846 1.3× 119 4.0k
Anne O’Neill United States 30 1.8k 1.1× 822 0.9× 587 0.7× 546 0.8× 505 0.8× 89 3.5k
Jill Gilbert United States 33 2.1k 1.3× 1.2k 1.3× 1.1k 1.4× 1.3k 1.9× 1.1k 1.6× 91 4.5k
Madeleine Kane United States 25 1.4k 0.8× 1.6k 1.8× 751 0.9× 360 0.5× 854 1.3× 59 4.0k
Shyh‐Kuan Tai Taiwan 28 1.3k 0.8× 443 0.5× 598 0.7× 584 0.8× 1.5k 2.3× 84 3.0k
Jared Weiss United States 27 3.0k 1.8× 1.2k 1.3× 534 0.6× 808 1.1× 702 1.1× 53 3.7k
Xavier León Spain 32 1.3k 0.8× 1.0k 1.2× 1.5k 1.8× 1.5k 2.2× 630 0.9× 219 3.5k
Kuan‐Der Lee Taiwan 27 945 0.6× 520 0.6× 1.4k 1.7× 125 0.2× 1.5k 2.3× 98 4.1k
Ashwatha Narayana United States 29 808 0.5× 1.3k 1.5× 592 0.7× 787 1.1× 485 0.7× 64 3.0k
Michael N. Needle United States 31 2.5k 1.5× 1.9k 2.1× 654 0.8× 189 0.3× 1.0k 1.6× 72 5.3k

Countries citing papers authored by Sana D. Karam

Since Specialization
Citations

This map shows the geographic impact of Sana D. Karam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sana D. Karam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sana D. Karam more than expected).

Fields of papers citing papers by Sana D. Karam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sana D. Karam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sana D. Karam. The network helps show where Sana D. Karam may publish in the future.

Co-authorship network of co-authors of Sana D. Karam

This figure shows the co-authorship network connecting the top 25 collaborators of Sana D. Karam. A scholar is included among the top collaborators of Sana D. Karam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sana D. Karam. Sana D. Karam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ross, Richard B., Jacob Gadwa, Justin Yu, et al.. (2024). PPARα Agonism Enhances Immune Response to Radiotherapy While Dietary Oleic Acid Results in Counteraction. Clinical Cancer Research. 30(9). 1916–1933. 2 indexed citations
3.
Kim, Dong‐Wan, Byoung Chul Cho, Sang‐We Kim, et al.. (2024). Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study. Lung Cancer. 190. 107530–107530. 5 indexed citations
4.
Ormond, D. Ryan, et al.. (2023). Short-term topiramate treatment prevents radiation-induced cytotoxic edema in preclinical models of breast-cancer brain metastasis. Neuro-Oncology. 25(10). 1802–1814. 5 indexed citations
5.
Chiaro, Marco Del, Toshitaka Sugawara, Sana D. Karam, & Wells A. Messersmith. (2023). Advances in the management of pancreatic cancer. BMJ. 383. e073995–e073995. 51 indexed citations
6.
Boss, Mary‐Keara, et al.. (2023). Canine oral squamous cell carcinoma as a spontaneous, translational model for radiation and immunology research. Frontiers in Oncology. 12. 1033704–1033704. 9 indexed citations
7.
Marquez-Ortíz, Ricaurte Alejandro, Vesna Tešić, James C. Costello, et al.. (2021). IL13Rα2 Promotes Proliferation and Outgrowth of Breast Cancer Brain Metastases. Clinical Cancer Research. 27(22). 6209–6221. 22 indexed citations
8.
Stokes, William A., Jessica D. McDermott, Rustain Morgan, et al.. (2021). Survival impact of angiotensin‐converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer. Head & Neck. 43(11). 3255–3275. 7 indexed citations
9.
Bickett, Thomas E., Michael W. Knitz, Laurel B. Darragh, et al.. (2021). FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC. Clinical Cancer Research. 27(22). 6235–6249. 22 indexed citations
10.
Oweida, Ayman, Adam C. Mueller, Miles Piper, et al.. (2020). Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide. Cancer Immunology Immunotherapy. 70(4). 989–1000. 27 indexed citations
11.
Young, Christian D., Li Bian, Kelsey Weigel, et al.. (2020). PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models. Clinical Cancer Research. 26(12). 3058–3070. 25 indexed citations
12.
Bhatia, Shilpa, Ayman Oweida, Shelby Lennon, et al.. (2019). Inhibition of EphB4–Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers. Cancer Research. 79(10). 2722–2735. 38 indexed citations
13.
Karam, Sana D. & David Raben. (2019). Radioimmunotherapy for the treatment of head and neck cancer. The Lancet Oncology. 20(8). e404–e416. 68 indexed citations
14.
Bhatia, Shilpa, Shelby Lennon, Ayman Oweida, et al.. (2018). Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor. Molecular Cancer Therapeutics. 17(9). 2049–2059. 9 indexed citations
15.
Karam, Sana D., Krishna Reddy, Patrick J. Blatchford, et al.. (2018). Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer. Clinical Cancer Research. 24(20). 4949–4959. 68 indexed citations
16.
Bhatia, Shilpa, Jaspreet Sharma, Sanjana Bukkapatnam, et al.. (2018). Inhibition of EphB4–Ephrin-B2 Signaling Enhances Response to Cetuximab–Radiation Therapy in Head and Neck Cancers. Clinical Cancer Research. 24(18). 4539–4550. 23 indexed citations
17.
Oweida, Ayman, Mohammad K. Hararah, Andy V. Phan, et al.. (2018). Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration. Clinical Cancer Research. 24(21). 5368–5380. 209 indexed citations
18.
Sumner, Whitney, Arya Amini, Todd C. Hankinson, et al.. (2017). Survival benefit of postoperative radiation in papillary meningioma: Analysis of the National Cancer Data Base. Reports of Practical Oncology & Radiotherapy. 22(6). 495–501. 12 indexed citations
19.
Oweida, Ayman, Shilpa Bhatia, Todd M. Pitts, et al.. (2016). Ephrin‐B2 overexpression predicts for poor prognosis and response to therapy in solid tumors. Molecular Carcinogenesis. 56(3). 1189–1196. 33 indexed citations
20.
Karam, Sana D., Abdul Rashid, Ann K. Jay, et al.. (2013). Trigeminal neuralgia treatment outcomes following Gamma Knife radiosurgery with a minimum 3-year follow-up. Journal of Radiation Oncology. 3(2). 125–130. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seungwon Kim Breakdown of academic impact, for papers by Anne O’Neill Breakdown of academic impact, for papers by Jill Gilbert Breakdown of academic impact, for papers by Madeleine Kane Breakdown of academic impact, for papers by Shyh‐Kuan Tai Breakdown of academic impact, for papers by Jared Weiss Breakdown of academic impact, for papers by Xavier León Breakdown of academic impact, for papers by Kuan‐Der Lee Breakdown of academic impact, for papers by Ashwatha Narayana Breakdown of academic impact, for papers by Michael N. Needle
Rankless by CCL
2026